LISTING PROSPECTUS / SHAREHOLDERS' CIRCULARS
LUYE PHARMA GROUP LTD.
Information Memorandum
28 Oct 2024
U.S.$100,000,000 5.85 per cent. Convertible Bonds due 2025
Description:
U.S.$100,000,000 5.85 PER CENT. CONVERTIBLE BONDS DUE 2025
Attached document:
Luye Pharma Group Ltd._HKO1-2007828754-v1 CB 2024 - Final IM (Tranche A).pdf
0.93 MB